Could removing extra tissue during Crohn's surgery cut relapse risk?

NCT ID NCT06856044

Recruiting now Disease control Sponsor: Centre Hospitalier Universitaire de Nīmes Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 09, 2026 · Updated 26 times

Summary

This study tests whether removing the mesentery (a fatty tissue near the intestine) during surgery for Crohn's disease is safe and helps prevent the disease from coming back. About 30 adults with Crohn's who are on biotherapy and need ileocolic surgery will take part. The main goal is to see if this surgery causes no more complications than standard surgery, and if it lowers the chance of recurrence within 6 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

CHU de Montpellier Hôpital St Eloi
RECRUITING

Montpellier, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
CHU de Nîmes
RECRUITING

Nîmes, 30029, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

CROHN DISEASE